FDP fibrinogen degradation product test kit (latex enhanced immune turbidimetry)

[FDP] Fibrinogen degradation product test kit (latex enhanced immune turbidimetry)

Methodology: latex enhanced immune turbidimetry

Dosage form: liquid double reagent

storage: 2-8 ℃, dark storage

Registration certificate: ZXZZ 20162400836

Clinical significance: fibrinogen degradation products mainly reflect the increase of fibrinolytic function. See:

                 a) Primary hyperfibrinolysis

                  b) Secondary hyperfibrinolysis: disseminated intravascular coagulation in hypercoagulable state, renal disease, thrombolytic therapy for organ transplantation rejection, etc

                  c) Vascular embolism disease (myocardial infarction, occlusive cerebrovascular disease, deep venous thrombosis)

                  d) Hemorrhagic thrombocytosis, uremia, liver disease or various tumors after induction of chemotherapy for leukemia

Intended use: This kit is used for quantitative determination of fibrinogen degradation products in human plasma in vitro. It is mainly used for auxiliary diagnosis of primary and secondary hyperfibrinolysis related diseases

Manufacturer: Zhejiang Aikang Biotechnology Co., Ltd.